... Because the optimal
postremission therapy for patients with ALL is still unclear, participation in clinical trials should be considered. ... Fiere D, Lepage E, Sebban C, et al.: Adult acute lymphoblastic leukemia: a...
http://cancerweb.ncl.ac.uk/cancernet/101024.html